LA Private

August 15, 2025

WAM Leaders (WLE) Boosts Fully Franked Full Year Dividend

WAM Leaders Limited (ASX: WLE), a listed investment company managed by Wilson Asset Management, has announced an increased fully franked full year dividend of 9.4 cents per share. The final dividend will be 4.7 cents per share, fully franked. This represents a fully franked dividend yield of 7.1% and a grossed-up dividend yield of 10.1%, […]

WAM Leaders (WLE) Boosts Fully Franked Full Year Dividend Read More »

Microequities (ASX:MAM) Announces Strong FY25 Results, Anticipates Continued Growth

Microequities Asset Management Group Limited (ASX:MAM), an Australian investment management firm specialising in listed industrial small and microcap companies, has released its FY25 financial results, showcasing significant growth in key metrics. The company reported a 19% increase in Net Profit After Tax (NPAT) to $7.1 million and a 39% increase in operating profit to $10.4

Microequities (ASX:MAM) Announces Strong FY25 Results, Anticipates Continued Growth Read More »

Microequities (MAM) Reports 19.3% Profit Increase, Declares Final Dividend

Microequities Asset Management Group Limited (MAM), an ASX-listed company managing investment funds, has announced a 19.3% increase in profit from ordinary activities after tax, attributable to owners, reaching $7,149,776 for the year ended 30 June 2025. This compares to $5,990,697 in the previous corresponding period. Revenue from ordinary activities also saw a rise of 9.3%,

Microequities (MAM) Reports 19.3% Profit Increase, Declares Final Dividend Read More »

Falcon Metals (ASX:FAL) Announces A$20 Million Placement to Accelerate Blue Moon Exploration

Falcon Metals Limited (ASX:FAL), a mineral exploration company focused on high-grade goldfields in Victoria, Australia, has announced a successful placement to raise A$20.0 million before costs. The placement, priced at A$0.57 per share, was led by high-quality institutions including North American, European, and Australian funds. Applications for the placement significantly exceeded the funds sought, demonstrating

Falcon Metals (ASX:FAL) Announces A$20 Million Placement to Accelerate Blue Moon Exploration Read More »

Siren Gold (ASX: SNG) Announces $4 Million Capital Raise

Siren Gold Limited (ASX: SNG), a New Zealand-focused gold exploration and development company, has announced it has secured firm commitments to raise $4 million through a placement to new and existing sophisticated and institutional investors. The company’s flagship asset, the Sams Creek Gold Project, hosts a JORC Mineral Resource Estimate (MRE) of 824,000 ounces of

Siren Gold (ASX: SNG) Announces $4 Million Capital Raise Read More »

Lakes Blue Energy Provides Drilling Update for Wombat-5 Well

Lakes Blue Energy (LKO) has released an update on drilling operations at its Wombat-5, side-track-1 (ST-1) well in the Gippsland Basin, Victoria. Lakes Blue Energy is an ASX-listed company focused on developing gas resources. The announcement details progress as of 8:00 am AEST today, indicating that the well has been operating for 15 days since

Lakes Blue Energy Provides Drilling Update for Wombat-5 Well Read More »

WAM Global (WGB) Reports Strong FY25 Results, Boosts Final Dividend

WAM Global Limited (WGB), a listed investment company providing investors with exposure to an actively managed diversified portfolio of high quality undervalued international growth companies and exposure to market mispricing opportunities, has announced its preliminary final report for the year ended 30 June 2025. The report showcases a substantial increase in revenue and profit compared

WAM Global (WGB) Reports Strong FY25 Results, Boosts Final Dividend Read More »

FDA Extends Review Timeline for Neurizon’s NUZ-001 Clinical Hold Response

Neurizon Therapeutics Limited (ASX: NUZ), a clinical-stage biotech company dedicated to advancing innovative treatments for neurodegenerative diseases, has announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for its Clinical Hold Complete Response (CHCR) to the Investigational New Drug (IND) application for NUZ-001. NUZ-001 is the company’s lead investigational therapy

FDA Extends Review Timeline for Neurizon’s NUZ-001 Clinical Hold Response Read More »

Ryder Capital (RDY) Announces Strong FY25 Results, Final Dividend

Ryder Capital Limited (RDY), an ASX-listed investment firm that invests in a concentrated portfolio of ASX-listed small to mid-capitalisation securities, bonds and cash, has announced its preliminary final report for the year ended 30 June 2025. The company reported a substantial increase in revenue from ordinary activities, reaching $30,953,879, up from the previous corresponding period.

Ryder Capital (RDY) Announces Strong FY25 Results, Final Dividend Read More »

Ryder Capital Announces Increased Dividend and Strong FY25 Performance

Ryder Capital Limited (ASX:RYD), a Sydney-based boutique fund manager specialising in small to mid-cap Australasian equities with a high conviction value driven investment strategy, has announced a 10% increase in its final dividend for FY25, rising to 5.5 cents per share fully franked. This decision follows a year of robust financial performance, marked by a

Ryder Capital Announces Increased Dividend and Strong FY25 Performance Read More »